The use of bilirubin oxidase to remove interference by bilirubinin hydrogenperoxide/peroxidasedetectingsystems is hampered by its inherent'chromogen oxidase"activity(its ability to oxidizethe chromogensused in the systems). This unwantedactivityis >99% inhibitedby 0.5 mmol/Lcyanide, 97% inhibited by 20 mmol/L azide. At these same concentrations, they inhibit bilirubin oxidase activityby 95% and 73%, respectively.Sequential additionof reagents allows the use of bilirubinoxidase without interference by the chromogen oxidase activity. A major drawback of BOX is that it will itself catalyze the oxidation of the chromogen system, acting as a "chromogen oxidase" in the absence of PODIH2O2 and producing a large reagent-blank absorbance.
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In the course of developing a colorimetric assay for serum 5'-nucleotidase (manuscript in preparation) based on the production of H202, I found that bilirubin interferes substantially. Before I could use BOX to eliminate this interference, it was necessary to find reaction conditions under which the chromogen oxidase activity of BOX was minimal. Experiments that achieved this objective are described.
Materials and Methods

Materials.
BOX was purchased from Amano Pharmaceutical Co., 2-7, 1-chome, Nishiki, Naku-ku, Nagoya 460, Japan. All other enzymes were from Sigma (London) Chemical Co., Ltd., Poole, Dorset, U.K. All chemicals were "Analar" grade, from BDH Chemicals Ltd., Poole, Dorset, U.K.
Tribromohydroxybenzoic acid was synthesized as described by Trinder and Webster (4).
Instruments.
For all experiments I used either of two centrifugal analyzers-a Multistat ifi (Instrumentation Laboratory (UK) Ltd., Warrington, U.K.) with red ifiter fitted to the heating lamps or a Cobas Bio (Roche Products Ltd., Welwyn Garden City, Herts., U.K.).
Bilirubin
solution. 
Bilirubin was dissolved in
Results and Discussion
Bilirubin interferes in H202/POD detecting systems because it is oxidized by this system. When all the bilirubin has been so oxidized, the interference ceases. This leads to a delay in oxidation of the chromogen. Indeed, there is an initial decrease in absorbance as the bilirubin is oxidized. The duration of the delay in chromogen oxidation depends on the rate of H202 production and therefore, in the 5'-nucleotidase assay, will be inversely related to the activity of 5'-nucleotidase in the sample. This leads to differences in sensitivity to bilirubin inhibition at different 5'-nucleotidase activities. The inhibition caused by 500 zmol of bilirubin per litre was 99% when the sample nucleotidase activity was 30 U/L but only 50% when its activity was 40 U/L. In assays for analytes other than enzymes in which only the initial and final absorbance is measured, the interference ought not to be affected by the analyte concentration.
In investigating the use of BOX to eliminate the interference by bilirubin I observed significant loss of BOX activity after overnight storage of solutions of it at 4 to -20 #{176}C. For maximum activity, only freshly prepared BOX solutions should be used. In subsequent studies the BOX solutions I used (0.1-10 g/L) were kept at 4 #{176}C and used the same day they were prepared.
BOX reacts preferentially with unbound bilirubin. The detergent sodium dodecyl sulfate, by removing bilirubin from albumin, enhances the degradation of bilirubin catalyzed by BOX ( Figure 1) ; in its absence 10-lbld more BOX was required to achieve a similar rate of bilirubin degradation (Figure 1) . BOX also oxidized the chromogens 4-aminophenazone and tribromohydroxybenzoic acid, the rate of color formation being proportional to BOX concentrations. At a concentration of BOX of 20 mg/L, the concentration used in the 5'- Ferrocyanide enhances the chromogen oxidase activity by several fold and therefore should not be included in the assay reagent. Fluoride partly inhibits the chromogen oxidase activity of BOX. However, the maximum inhibition was only 50% at a fluoride concentration of 10 mmolJL. Inhibition by azide or cyanide was more successful, 0.5 mmol of cyanide per litre sufficing to inhibit the chromogen oxidase activity of BOX by 99%, but also inhibiting the bilirubin-degrading activity by 95%. Azide, 20 mmolIL, inhibited the chromogen oxidase activity of BOX by 97% while inhibiting bilirubin degradation by 73%. Therefore, to use these inhibitors without affecting the degradation of bilirubin requires preincubation of the sample with BOX in the absence of inhibitors.
Cyanide interfered in the 5'-nucleotidase assay and therefore for this assay I used azide to inhibit BOX. Under the conditions described for the 5'-nucleotidase assay, interference from bilirubin in concentrations as great as 1000 mol/L was eliminated, the sample-blank being equivalent to an activity of only 0.4 U/L. Optimal concentrations of BOX and inhibitors remain to be determined for other H2O2/POD based assays. Nevertheless, use of the inhibitors described here should facilitate the wider use of BOX for removal of bilirubin interference.
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